Skip to main content
. 2008 Jun 23;336(7659):1475–1482. doi: 10.1136/bmj.39609.449676.25

Table 8.

 Clinical examples for patients who would be reclassified with QRISK2 instead of NICE modified Framingham equation

Age (years) Ethnic group Family history Systolic blood pressure BMI Cholesterol/HDL ratio Smoker Treated hypertension Type 2 diabetes* Chronic kidney disease Townsend score† Framingham score 10 year risk (%) QRISK2 10 year risk (%) (95% CI)
Men
65 Indian Yes 100 24.7 3.3 No No No No 5 17 31.3 (30.9 to 31.7)
54 Bangladeshi No 142 27.0 4.2 No Yes No No 10 17 23.5 (22.8 to 24.1)
54 Black African No 150 21.0 7.3 No No No No 4 23 9.0 (7.7 to 10.3)
55 Indian No 156 27.0 4.7 No No No No −4 24 12.7 (12.2 to 13.2)
65 Caribbean No 146 29.1 5.4 No No No No 4 26 14.8 (14.2 to 15.5)
42 White Yes 132 36.0 5.3 Yes Yes No No 11 17 35.2 (34.9 to 35.5)
Women
64 Indian No 130 23.1 5.3 No Yes No No 5 12 24.7 (24.4 to 25.0)
60 Bangladeshi No 132 36.0 4.3 No Yes No No 11 9 21.1 (20.6 to 21.6)
48 Pakistani Yes 140 33.2 4.5 No Yes No No 8 9 26.1 (25.7 to 26.4)
58 White No 154 34.0 3.4 Yes Yes No No 10 16 21.4 (21.3 to 21.5)

BMI=body mass index; HDL=high density lipoprotein cholesterol.

*NICE lipid modification guideline does not include diabetes so this is for illustrative purposes only.

†Interval score ranges between −6 (most affluent) and 11 (most deprived).